5/20/2022U.S., European Firms Rethink China Investment After Lockdowns

5/20/2022VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...

5/20/2022Recent Executive Moves

5/19/2022China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...

5/19/2022CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022

5/19/2022APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...

5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...

5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...

5/17/2022NHSA Completes Building of Unified National BMI Information Platform

5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...

5/16/2022Visus and Zhaoke Enter Exclusive Licensing Deal for Brimochol PF and C...

5/16/2022Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal

5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...

5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/13/2022SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021

5/12/2022Henlius and Eurofarma Entered into a License Deal for Three Henlius P...

5/12/2022Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...

5/12/2022China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...

5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...

5/11/2022NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...

5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021

5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation

5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021

5/6/2022Orion Enters into Exclusive Deal with Jemincare for Novel Non-Opioid D...

5/6/2022Drug R&D and Product Registration News Digest May 2022 (1)

5/6/2022Recent Executive Moves

5/4/2022BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

5/2/2022China Continues to Drop Reimbursements via DIP system: PBM

Page:44/333 Total number of articles:9989: [First][<<] [42] [43] [44] [45] [46] [>>] [End]